Exclusive: Is Selling Stock Like Pernix Therapeutics Holdings Inc After Such Decline Winning Strategy?

Exclusive: Is Selling Stock Like Pernix Therapeutics Holdings Inc After Such Decline Winning Strategy?

The stock of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) is a huge mover today! The stock decreased 5.03% or $0.16 on November 30, hitting $3.02. About 417,142 shares traded hands or 11.63% up from the average. Pernix Therapeutics Holdings Inc (NASDAQ:PTX) has declined 59.75% since April 27, 2016 and is downtrending. It has underperformed by 64.97% the S&P500.
The move comes after 9 months negative chart setup for the $28.16 million company. It was reported on Nov, 30 by Barchart.com. We have $2.84 PT which if reached, will make NASDAQ:PTX worth $1.69 million less.

Analysts await Pernix Therapeutics Holdings Inc (NASDAQ:PTX) to report earnings on March, 9.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX) Ratings Coverage

Out of 4 analysts covering Pernix Therapeutics (NASDAQ:PTX), 1 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 25% are positive. Pernix Therapeutics has been the topic of 9 analyst reports since August 7, 2015 according to StockzIntelligence Inc. Oppenheimer downgraded the stock to “Perform” rating in Thursday, March 17 report. As per Friday, August 12, the company rating was downgraded by Brean Capital. The stock of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) earned “Buy” rating by Brean Capital on Friday, March 11. The firm has “Market Outperform” rating by JMP Securities given on Wednesday, September 9. Brean Capital maintained it with “Buy” rating and $8 target price in Tuesday, February 9 report. Brean Capital maintained the shares of PTX in a report on Friday, August 7 with “Buy” rating. The stock of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) has “Hold” rating given on Friday, March 11 by Needham. On Friday, August 7 the stock rating was maintained by Needham with “Strong Buy”.

According to Zacks Investment Research, “Pernix Therapeutics Holdings Inc., formerly known as Golf Trust of America, Inc., is a specialty pharmaceutical company focused on developing and commercializing pharmaceutical products to meet medical needs primarily in pediatrics. The Company’s product families include Aldex, Pediatex, Z-Cof, Brovex, ReZyst and QuinZyme. Its ALDEX products are indicated for the treatment of allergies and symptoms of the common cold. PEDIATEX TD is for the treatment of respiratory allergies. Z-COF 8DM is for the treatment of allergies and symptoms of the common cold. The BROVEX products are indicated for the treatment of allergies and symptoms of the common cold. REZYST IM is a chewable tablet probiotic indicated to replace active cultures that are destroyed by diet and antibiotics and to reduce symptoms associated with irritable bowel syndrome and various gastrointestinal issues. QUINZYME is a dissolve tablet for patients with depleted ubiquinone levels and for patients on statin therapy. Pernix is based in Magnolia, Texas.”

Insitutional Activity: The institutional sentiment increased to 0.47 in Q2 2016. Its up 0.13, from 0.34 in 2016Q1. The ratio improved, as 38 funds sold all Pernix Therapeutics Holdings Inc shares owned while 21 reduced positions. 8 funds bought stakes while 12 increased positions. They now own 12.25 million shares or 66.36% less from 36.43 million shares in 2016Q1.
Wells Fargo & Mn accumulated 0% or 4,751 shares. Retail Bank Of Ny Mellon holds 44,965 shares or 0% of its portfolio. Pnc Fincl Services Grp Inc has 0% invested in the company for 551 shares. Blackrock Institutional Tru Na accumulated 710,276 shares or 0% of the stock. Moreover, Orbimed Advsr Ltd Liability has 0.01% invested in Pernix Therapeutics Holdings Inc (NASDAQ:PTX) for 1.07 million shares. D E Shaw And owns 33,995 shares or 0% of their US portfolio. Deutsche National Bank Ag has invested 0% of its portfolio in Pernix Therapeutics Holdings Inc (NASDAQ:PTX). Moreover, Oppenheimer & Comm Inc has 0% invested in Pernix Therapeutics Holdings Inc (NASDAQ:PTX) for 14,700 shares. Ladenburg Thalmann Svcs Inc last reported 50 shares in the company. Goodwin Daniel L last reported 0% of its portfolio in the stock. Moreover, Balyasny Asset Management Llc has 0% invested in Pernix Therapeutics Holdings Inc (NASDAQ:PTX) for 11,700 shares. Huntington Bancshares has invested 0% of its portfolio in Pernix Therapeutics Holdings Inc (NASDAQ:PTX). Moreover, Aisling Cap Ltd has 0.21% invested in Pernix Therapeutics Holdings Inc (NASDAQ:PTX) for 2.01M shares. Barclays Public Ltd Company accumulated 5,435 shares or 0% of the stock. Moreover, Highland Cap Lc has 0% invested in Pernix Therapeutics Holdings Inc (NASDAQ:PTX) for 41,000 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment